More than 40 years in pursuit of excellence. A new chapter.
A goal that matters
Since its founding, Quality Assistance has pursued one goal: getting innovative medicines to patients faster, without compromising on quality.
We work alongside those who seek, discover and develop. Researchers, laboratories, large pharma company and biotechs venturing into uncharted territory. Their mission demands absolute commitment from us. When you support therapeutic innovation from discovery to market, precision is not optional. It is a responsibility.
In 2026, Quality Assistance enters a new dimension.
Investments that match your needs and our ambitions
Quality Assistance enters a new phase of development.
We are significantly expanding our operational capacity to support a growing number of projects, increased complexity of therapeutic modalities, and new geographic ambitions, particularly in international markets.
At the same time, we are launching our Pharma Academy: 650 sqm fully dedicated to training and developing expertise. Because the standards we expect from our teams must always reflect the highest standards we commit to our partners
An identity that reflects who we have become
This new identity is the result of a collaborative effort between management, the marketing team, R&D experts and operational experts: an in-depth reflection on what drives us and the direction we want to take. Our teams, supported by the work and advice of the Reed agency, have all contributed to shaping this new chapter.
Our ambition deserved an expression to match. A bolder identity, a more modern voice, a website that reflects our momentum. This rebrand captures the energy that drives us forward.
What remains our compass
A world where innovative medicines reach patients with uncompromising speed and quality. Every investment, every evolution, every hire is guided by this vision. Our new identity is an affirmation of what has always defined Quality Assistance.
2026, a new chapter. Rooted in our DNA, driven by excellence
We unveil this new face at the start of a new year. To all those with ambitious projects, advancing science in service of patients: future candidates, partners and of course drug developers.
Let's build what comes next, together.